Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-muscle-invasive Bladder Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04799847
What this trial is testing

Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine

Who this might be right for
Bladder Cancer
LintonPharm Co.,Ltd. 161
Not applicableLooking for participantsNCT05825950
What this trial is testing

Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-muscle-invasive Bladder Cancer
University of Texas Southwestern Medical Center 600
Testing effectiveness (Phase 2)Study completedNCT02009332
What this trial is testing

Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Aadi Bioscience, Inc. 21
Testing effectiveness (Phase 2)UnknownNCT04101812
What this trial is testing

Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Cancer
Tianjin Medical University Second Hospital 60
Not applicableUnknownNCT05084586
What this trial is testing

Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation

Who this might be right for
Bladder CancerEpirubicin Adverse ReactionSuperficial Bladder Cancer+1 more
Ankara Training and Research Hospital 100
Not applicableStudy completedNCT07534631
What this trial is testing

Holmium Laser En-Bloc Resection Versus Conventional Transurethral Resection of Bladder Tumors for Treatment of Non-muscle- Invasive Bladder Cancer

Who this might be right for
Bladder Tumor (TURBT)
Beni-Suef University 100
Large-scale testing (Phase 3)UnknownNCT00816075
What this trial is testing

Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection

Who this might be right for
Recurrent Superficial Bladder CancerDistilled Water
Bozyaka Training and Research Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06310369
What this trial is testing

Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 50
Large-scale testing (Phase 3)Ended earlyNCT01438112
What this trial is testing

Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer

Who this might be right for
Transitional Cell CarcinomaBladder CancerCarcinoma in Situ+1 more
CG Oncology, Inc. 22
Early research (Phase 1)Looking for participantsNCT05519241
What this trial is testing

A Phase I Intravesical PPM Therapy for NMIBC

Who this might be right for
Non-muscle-invasive Bladder Cancer
VA Office of Research and Development 29
Testing effectiveness (Phase 2)Study completedNCT04498702
What this trial is testing

Study of Continuous APL-1202 Treatment in Subjects With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Relapsed From Intravesical Chemo/BCG Therapy

Who this might be right for
Non-muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 41
Not applicableStudy completedNCT01304173
What this trial is testing

Retrospective Chart Review of Valstar

Who this might be right for
Carcinoma in Situ of Bladder
Endo USA Inc., a Keenova Therapeutics Company 113
Testing effectiveness (Phase 2)Active Not RecruitingNCT04375813
What this trial is testing

Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

Who this might be right for
Non-muscle Invasive Bladder Cancer
Robert Svatek 166
Large-scale testing (Phase 3)Looking for participantsNCT06319820
What this trial is testing

Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC 641
Not applicableEnded earlyNCT04142359
What this trial is testing

PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)

Who this might be right for
Pharmacokinetics
Altor BioScience 1
Early research (Phase 1)Active Not RecruitingNCT05843448
What this trial is testing

IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer

Who this might be right for
High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more
University of California, Davis 6
Large-scale testing (Phase 3)Active Not RecruitingNCT06111235
What this trial is testing

Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

Who this might be right for
Non Muscle Invasive Bladder CancerUrologic CancerBladder Cancer+1 more
CG Oncology, Inc. 367
Testing effectiveness (Phase 2)Looking for participantsNCT05327647
What this trial is testing

A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Cancer
CHU de Quebec-Universite Laval 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06630871
What this trial is testing

A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk.

Who this might be right for
NMIBC
Fujian Medical University Union Hospital 40
Not applicableNot Yet RecruitingNCT06678633
What this trial is testing

T-Control® Safety for Cytostatics Management

Who this might be right for
Non-muscle-invasive Bladder Cancer
Rethink Medical SL 16
Next Page